Search

Author/Creator Lublin, Fred

1. Restoring immune tolerance in neuromyelitis optica: Part I. Issue 5 (October 2016)

Authors:
Steinman, Larry; Bar-Or, Amit; Behne, Jacinta M.; Benitez-Ribas, Daniel; Chin, Peter S.; Clare-Salzler, Michael; Healey, Donald; Kim, James I.; Kranz, David M.; Lutterotti, Andreas; Martin, Roland; Schippling, Sven; Villoslada, Pablo; Wei, Cheng-Hong; Weiner, Howard L.; Zamvil, Scott S.; Yeaman, ...
Journal:
Neurology
Issue:
Volume 3:Issue 5(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Restoring immune tolerance in neuromyelitis optica: Part II. Issue 5 (October 2016)

Authors:
Bar-Or, Amit; Steinman, Larry; Behne, Jacinta M.; Benitez-Ribas, Daniel; Chin, Peter S.; Clare-Salzler, Michael; Healey, Donald; Kim, James I.; Kranz, David M.; Lutterotti, Andreas; Martin, Roland; Schippling, Sven; Villoslada, Pablo; Wei, Cheng-Hong; Weiner, Howard L.; Zamvil, Scott S.; Smith, T...
Journal:
Neurology
Issue:
Volume 3:Issue 5(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Psychological resilience is linked to motor strength and gait endurance in early multiple sclerosis. (August 2020)

Authors:
Klineova, Sylvia; Brandstadter, Rachel; Fabian, Michelle T; Sand, Ilana Katz; Krieger, Stephen; Leavitt, Victoria M; Lewis, Christina; Riley, Claire S; Lublin, Fred; Miller, Aaron E; Sumowski, James F
Journal:
Multiple sclerosis
Issue:
Volume 26:Number 9(2020)
Page Start:
1111
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials. (October 2020)

Authors:
Zhang, Yinan; Gonzalez Caldito, Natalia; Shirani, Afsaneh; Salter, Amber; Cutter, Gary; Culpepper, William; Wallin, Mitchell; Kosa, Peter; Bielekova, Bibiana; Lublin, Fred; Stuve, Olaf
Journal:
Therapeutic advances in neurological disorders
Issue:
Volume 13(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial. Issue 7 (July 2022)

Authors:
Foley, John F; Defer, Gilles; Ryerson, Lana Zhovtis; Cohen, Jeffrey A; Arnold, Douglas L; Butzkueven, Helmut; Cutter, Gary; Giovannoni, Gavin; Killestein, Joep; Wiendl, Heinz; Smirnakis, Karen; Xiao, Shan; Kong, George; Kuhelj, Robert; Campbell, Nolan; van der Walt, Anneke; Dwyer, Christopher; Bu...
Journal:
Lancet neurology
Issue:
Volume 21:Issue 7(2022)
Page Start:
608
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗